Amgen Building On Repatha Experience As It Grows In Cardiovascular, Obesity

Execs Shared Strategy At J.P. Morgan Meeting

 
• By Mandy Jackson
  
Amgen has invested millions in physician and patient education already in support of Repatha (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Market Access